Bibliography

Original Reports/Peer Reviewed Journals:

  • Ahmed Z, Kragie L,Connor JA. 1980 Stoichiometry and apparent dissociation constant of the calcium-arsenazo III reaction under physiological conditions. Biophysical Journal 32: 907-920
  • Kragie L, Doyle D. 1992 Benzodiazepines inhibit temperature-dependent [125]I-L-triiodo-thyronine accumulation into human liver, human neuroblast and rat pituitary cell lines. Endocrinology 130: 1211-1216
  • Kragie L, Sekovski B. 1992 Theophylline -- an alternative therapy for bradyarrhythmia in the elderly. Pharmacotherapy 12:324-330
  • Kragie L. 1992 Requisite structural characteristics for benzodiazepine inhibition of triiodothyronine uptake into a human liver cell line. Life Sciences, Pharmacology Letters 51: PL83-PL88
  • Kragie L. 1993 Neuropsychiatric implications of thyroid hormone-benzodiazepine interactions. Endocrine Research 19: 1-32
  • Kragie L, Kwon YW, Smiehorowski R. 1993 Rat cardiac calcium channels and their relationships with b-adrenergic and muscarinic receptors in hypothyroidism. Endocrine Research19: 57-71
  • Kragie L, Smiehorowski R. 1993 Measures of skeletal muscle calcium channels and acetylcholine receptors in thyroidectomized rats. Endocrine Research 19: 207-219
  • Kragie L, Stock ME. 1994 Acetylcholinesterase activity in fast-twitch skeletal muscle from thyroidectomized rats. Endocrine Research 20: 47-57
  • Kragie L, Forrester ML, Cody V, McCourt M. 1994 Computer-assisted molecular modeling of benzodiazepine and thyromimetic inhibitors of the HepG2 iodothyronine transporter. Molecular Endocrinology 8: 382-391
  • Kragie L, Smiehorowski R. 1994 Altered peripheral benzodiazepine receptor binding in cardiac and liver tissues from thyroidectomized rats. Life Sciences 55 (24): 1911-1918
  • Kragie L. 1994 Membrane iodothyronine transporters part I: review of physiology. Endocrine Research 20 (4): 319-342
  • Kragie L. 1996 Membrane iodothyronine transporters part II: review of protein biochemistry. Endocrine Research 22 (2):95-119
  • Lukas SE, Sholar M, Lundahl J, Lamas X, Kouri E, Wines JD, Kragie L, Mendelson JH. 1996 Sex differences in plasma cocaine levels and subjective effects after acute cocaine administration in human volunteers. Psychopharmacology 125: 346-354
  • Kragie L. 1999 Today's Telemedicine. Healthcare Trends Report 13(6): 1-15
  • Kragie L, Simmons JE. 1999 Book Review: Principles of Process Research and Chemical Development in the Pharmaceutical Industry by O. Repic.The Alchemist April 9 1999 [http://chemweb.com/alchem/1999/books/bk_990409_repic.html]
  • Kragie L. 2000 Book Review: The Science and Technology Behind the Human Genome Project by Charles R. Cantor and Cassandra L. Smith. The Alchemist February 3 2000 [http://chemweb.com/alchem/2000/books/bk_000203_cantor.html]
  • Kragie L, Turner SD, Patten CJ, Crespi CL, Stresser DM. 2002 Assessing pregnancy risks of azole antifungals using a high throughput aromatase inhibition assay. Endocrine Research 28 (3): 129-140
  • Kragie L. 2002 Aromatase in primate pregnancy: a review. Endocrine Research 28 (3): 121-128
  • Kragie L. 2006 Another Reorganization at FDA: Office of Translational Sciences. What It Means For You. Life Sciences Due Diligence & Regulatory Analysis, Vol 1; Issue 1

Abstracts of Presentations at Scientific Society Meetings:

  • Kragie L, Ahmed Z, Connor JA, Davis PJ. Neuronal CaATPase activity and changes in intracellular Ca2+ induced by short-term exposure to thyroid hormone. Society for Neuroscience Annual Mtg, 1985 [Abstract #164.10]
  • Kragie L, Schoenl M, Lawrence WD, Davis PJ. CNS effects of thyroid hormone involve stimulation of cytosolic protein kinase activity. Society for Neuroscience Annual Mtg, 1987 [Program Abstract #182.7]
  • Kragie L, Doyle D. Benzodiazepines inhibit triiodothyronine transport into human liver cell line. Society for Neuroscience Annual Meeting, 1990 [Program Abstract #36.19]
  • Kragie L, Doyle D. Benzodiazepine inhibition of triiodothyronine uptake into human liver cell line has a unique structure activity relationship. Society for Neuroscience Annual Mtg, 1991 [Abstract #537.10]
  • Kragie L, Forrester ML, Cody V. Structural characteristics of benzodiazepine compounds which inhibit triiodothyronine cellular uptake. The 74th Annual Endocrine Society Mtg, 1992 [Abstract #428]
  • Kragie L, Forrester ML, Cody V. Comparison of benzodiazepine inhibitors of thyroid hormone cellular uptake to thyroid hormones, using crystallographic computer modeling. 23rd National Medicinal Chemistry Symposium, Division American Chemical Society, 1992 [Abstract]
  • Kragie L, Smiehorowski R. Peripheral benzodiazepine receptor binding in hypothyroid rat ventricles. Society for Neuroscience Annual Meeting, 1992 [Abstract #486.15]
  • Kragie L, Smiehorowski R, Goonawardena D. Putative iodothyronine transporter membrane proteins from liver and brain as identified with antibodies and ligand affinity chromatography. The 75th Annual Endocrine Society Mtg, 1993 [Abstract #818]
  • Lui Y, Kragie L, Smiehorowski R, Marfella C, Lakshmanan M. Polyclonal antibodies to benzodiazepine binding proteins decrease triiodothyronine uptake into mouse neuroblasts. American Federation for Clinical Research Mtg, 1994 [Abstract]
  • Lakshmanan M, McCourt M, Lui Y, Kragie L. Thyroid hormone plasma membrane transport: structural homology and binding site interactions with aminoacids and benzodiazepines. The American Thyroid Association Annual Mtg, 1994. [Abstract]
  • Kragie L, McCourt M, Lakshmanan M. Modeling the iodothyronine and aminoacid transport sites in mouse neuroblastoma cells. 77th Annual Endocrine Society Mtg, 1995 [Abstract #P3-422] p 574
  • Kragie L, Amri H, Gore L, Flockhart D, Papadopoulos V. Cytochrome P450 Aromatase: An In Vitro Screening Tool for Drug-Steroid Interactions. The 10th International Congress of Endocrinology, 1996 [Abstract #P3-480] p 874
  • Stresser DM, Turner SD, Ho T, Crespi CL, Kragie L. Aromatase Inhibition by Azole Drugs: Assessing Pregnancy Risks. Society of Toxicology Annual Meeting, Nashville TN, March 2002
  • Kragie L, Stresser DM, Turner SD, Patten CJ, Crespi CL. Assessing pregnancy risks using a high throughput aromatase inhibition assay. ASCPT Annual Meeting, Atlanta GA, March 2002. [Abstract #TPII-94] Clinical Pharmacology & Therapeutics Feb 2002; 71(2): P67
  • Castelli C, Fotso J, Tiano D, Kragie L. An Evaluation of the Pharmacokinetic Profile of Naritriptan in Rats Following the Oral Administration of Naritriptan Combined with Eligen Carriers (Functional Excipients). ASCPT Annual Meeting, Orlando FL, April 2008. [Abstract #PI-73] Clinical Pharmacology & Therapeutics March 2008; 83(suppl): S32